172 countries and Multiple Candidate Vaccines Engaged in COVID-19 Vaccine Global Access Facility

172 economies are now engaged in discussions to potentially participate in COVAX, a global initiative aimed at working with vaccine manufacturers to provide countries worldwide equitable access to safe and effective vaccines, once they are licensed and approved. COVAX currently has the world’s largest and most diverse COVID-19 vaccine portfolio – including nine candidate vaccines, with a further nine under evaluation and conversations underway with other mayor producers.

Publication Year:

2020

Publisher

SPARC

Author:

WHO
  • Browse by Topic

  • Browse by Language

  • Browse by Format

Scroll to top

Join the SPARC Mailing list!

Get the latest news and resources on strategic purchasing